HIGHLIGHTS
- who: Giovanni Maria Iannantuono et al. from the Medical Oncology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier , have published the article: The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer, in the Journal: (JOURNAL) of 20/05/2022
- what: This study showed an improvement in terms of the objective response rate (ORR) and median progression-free survival (mPFS) for dMMR colorectal cancer (CRC) and non-CRC patients compared to pMMR CRC patients . In 2019, Antonarakis et_al published the first single-center retrospective study aiming . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.